P.A.W. Capital’s AbbVie ABBV Stock Holding History

P.A.W. Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.91M	Sell	11,555 -200	-2%	-$43K	2.23%	13
2026 Q1	$2.54M	Buy	+11,755	New	+$2.61M	2.87%	12
2022 Q4	–	Sell	-5,500	Closed	-$738K	–	26
2022 Q3	$738K	Hold	5,500	–	–	1.11%	41
2022 Q2	$842K	Sell	5,500 -500	-8%	-$76.4K	1.22%	36
2022 Q1	$973K	Sell	6,000 -1,000	-14%	-$145K	1.02%	26
2021 Q4	$948K	Hold	7,000	–	–	0.87%	27
2021 Q3	$755K	Hold	7,000	–	–	0.67%	54
2021 Q2	$788K	Hold	7,000	–	–	0.66%	53
2021 Q1	$758K	Hold	7,000	–	–	0.67%	49
2020 Q4	$750K	Hold	7,000	–	–	0.66%	35
2020 Q3	$613K	Hold	7,000	–	–	0.67%	41
2020 Q2	$687K	Sell	7,000 -1,000	-13%	-$88K	0.78%	27
2020 Q1	$610K	Hold	8,000	–	–	0.82%	34
2019 Q4	$708K	Hold	8,000	–	–	0.75%	36
2019 Q3	$606K	Hold	8,000	–	–	0.76%	53
2019 Q2	$582K	Buy	8,000 +500	+7%	+$39.3K	0.63%	53
2019 Q1	$604K	Buy	7,500 +1,000	+15%	+$81.8K	0.6%	52
2018 Q4	$599K	Hold	6,500	–	–	0.75%	43
2018 Q3	$615K	Hold	6,500	–	–	0.65%	51
2018 Q2	$602K	Buy	6,500 +500	+8%	+$48.8K	0.61%	54
2018 Q1	$568K	Sell	6,000 -1,500	-20%	-$165K	0.68%	52
2017 Q4	$725K	Sell	7,500 -1,500	-17%	-$141K	0.91%	38
2017 Q3	$800K	Sell	9,000 -16,000	-64%	-$1.22M	0.84%	51
2017 Q2	$1.81M	Sell	25,000 -1,000	-4%	-$67.2K	1.82%	17
2017 Q1	$1.69M	Hold	26,000	–	–	1.71%	19
2016 Q4	$1.63M	Hold	26,000	–	–	1.84%	21
2016 Q3	$1.64M	Sell	26,000 -9,000	-26%	-$583K	1.76%	21
2016 Q2	$2.17M	Buy	35,000 +5,000	+17%	+$305K	2.48%	11
2016 Q1	$1.71M	Sell	30,000 -5,000	-14%	-$279K	1.92%	15
2015 Q4	$2.07M	Hold	35,000	–	–	2.35%	11
2015 Q3	$1.9M	Sell	35,000 -2,000	-5%	-$130K	2.18%	15
2015 Q2	$2.49M	Hold	37,000	–	–	2.51%	8
2015 Q1	$2.17M	Buy	37,000 +25,000	+208%	+$1.51M	2.14%	12
2014 Q4	$785K	Sell	12,000 -600	-5%	-$37.8K	0.83%	39
2014 Q3	$728K	Sell	12,600 -1,400	-10%	-$77.7K	0.68%	45
2014 Q2	$790K	Hold	14,000	–	–	0.79%	43
2014 Q1	$720K	Hold	14,000	–	–	0.71%	40
2013 Q4	$739K	Buy	14,000 +2,000	+17%	+$98.3K	0.66%	43
2013 Q3	$537K	Hold	12,000	–	–	0.45%	54
2013 Q2	$496K	Buy	+12,000	New	+$525K	0.42%	53

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

P.A.W. Capital's ABBV Position: Q2 2026 in Review

P.A.W. Capital reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $43K and leaving 11,555 shares worth $2.91M. The position accounts for 2.23% of the portfolio, ranked #13.

P.A.W. Capital first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

P.A.W. Capital held 11,555 shares of AbbVie worth $2.91M as of Q2 2026.
P.A.W. Capital sold 200 AbbVie shares in Q2 2026, an estimated $43K.
AbbVie made up 2.23% of P.A.W. Capital's portfolio in Q2 2026, its #13 holding.
P.A.W. Capital first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on P.A.W. Capital's 13F filing for Q2 2026, filed 28 Jul 2026.